Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Radiotherapy 10Cisplatin 9pembrolizumab 6Surveys and Questionnaires 6Methods 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5fludarabine 4Papillomavirus Vaccines 4Early Intervention, Educational 4Cyclophosphamide 4Brachytherapy 4durvalumab 3aldesleukin 3Vaccines, Synthetic 3Vaccines 3Sentinel Lymph Node Biopsy 3Radiosurgery 3Radiation 3Platinum 3Palliative Care 3Paclitaxel 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Drug Therapy 3Carboplatin 3Bleomycin 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × antineoplaston AS 2-1 × Gynecologic × Clear all
NCT00003525 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Burzynski Research Institute

Phase 2 Terminated
8 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡